Dato-DXd trials for Breast cancer

All Dato-DXd trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Dato-DXd for Breast cancer

• A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
  NCT06103864 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 320 locations
• A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
  NCT07205822 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 40 locations
• A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
  NCT06508216 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Dato-DXd for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.